Candel Therapeutics CADL - オプションチェーン | ADVFN

US Dollar vs Yen

登録してリアルタイムのチャート、分析ツール、価格を入手してください。

登録

ホーム
投資
株式
アメリカ
NASDAQ
Candel Therapeutics Inc (CADL)
Candel Therapeutics Inc (CADL) オプション

Candel Therapeutics Inc (CADL)

4.00

0.045

( 1.14% )

更新日時： 05:01:53

CADL ライブオプションフロー

オプションコール

行使価格	買値	売値	前回の価格	中間価格	前日比	前日比 %	出来高	建玉	最終取引
1.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
2.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
3.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
4.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
5.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
6.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
7.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
8.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
9.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
10.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
11.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-

個人投資家向けのプロ仕様のツール。

プレミアム

オプションプット

行使価格	買値	売値	前回の価格	中間価格	前日比	前日比 %	出来高	建玉	最終取引
1.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
2.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
3.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
4.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
5.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
6.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
7.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
8.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
9.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
10.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
11.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-

出来高
値上がり率
値下がり率

銘柄コード	株価	出来高
PRFXPainReform Ltd	US$ 1.2307 (130.04%)	181.04M
SMCXDefiance Daily Target 2X Long SMCI ETF	US$ 41.83 (63.91%)	3.7M
NCNCnoco noco Inc	US$ 0.157699 (62.58%)	743.91M
NXTTNext Technology Holding Inc	US$ 2.7193 (59.96%)	1.89M
ACRSAclaris Therapeutics Inc	US$ 4.791 (52.58%)	51.36M
DFLIDragonfly Energy Holdings Corporation	US$ 0.3305 (-34.15%)	2.75M
SLNSilence Therapeutics PLC	US$ 7.3865 (-32.97%)	3.45M
AKTXAkari Therapeutics PLC	US$ 1.56 (-31.88%)	277.81k
DMNDamon Inc	US$ 1.67 (-30.71%)	836.71k
QMMMQMMM Holdings Limited	US$ 1.26 (-27.17%)	4.32M
NCNCnoco noco Inc	US$ 0.157699 (62.58%)	736.6M
SYRSSyros Pharmaceuticals Inc	US$ 0.2969 (49.35%)	345M
WBUYWeBuy Global Ltd	US$ 0.196001 (23.19%)	246.49M
SMCISuper Micro Computer Inc	US$ 28.44 (32.03%)	196.83M
PRFXPainReform Ltd	US$ 1.2307 (130.04%)	179.69M

falcon21

falcon21 2週前

this stock is the laughing stock what I'm I missing anyone else feel that way

falcon21

falcon21 2週前

this stock is the laughing stock what I'm I missing anyone else feel that way

PonkenPlonken

PonkenPlonken 3週前

I love the CEO - was at Flagship and Chief Immunology Officer at GSK. Parachuted in to finish the job.

The panc data was the best i have ever seen.... You rarely read about such a 36 month surival here. 47% -- atleast the rest of the market was equally surprised their appoach works.
Eventually CAN3110 will be used in all cancers that express nectin

PonkenPlonken

PonkenPlonken 3週前

https://x.com/paulpetertak/status/1850866975515259299

falcon21

falcon21 3週前

why so quiet on this board great stock no news

PonkenPlonken

PonkenPlonken 1月前

good opportunity prior to the readouts

TechandBio

TechandBio 2月前

Candel yearly range is.60 range to $15.00 low to high if you find cancer stocks that are disruptive big gains potential. I see similar potential with ICCM IceCure kills breast cancer and Lung cancer with 97% non recurrence rate 5 years out. No outstanding debt or warrants.

ICCM
https://d1io3yog0oux5.cloudfront.net/_bc04737bc474935b6b12dfea965ac04e/icecuremedical/db/2291/21959/pdf/IceCure+Medical+%28ICCM%29+Company+Presentation+-+29-Aug-2024+FINAL.pdf

https://www.prnewswire.com/news-releases/icecure-medical-reports-final-ice3-breast-cancer-cryoablation-trial-results-of-100-patient-and-physician-satisfaction-and-96-3-recurrence-free-rate-data-submitted-to-fda-requesting-marketing-authorization-to-treat-early-stage-b-302116526.html

$CADL

Monksdream

Monksdream 2月前

Monksdream

Monksdream 3月前

Monksdream

Monksdream 3月前

CADL 10Q due AUGUST 19

Monksdream

Monksdream 3月前

CADL 10Q due MONDAY AUGUST 12

Monksdream

Monksdream 4月前

TechandBio

TechandBio 4月前

Cancer Killing Platforms. Candel and IceCure. I only bought a 5000 shares of $CADL at .88 sold half at 9.00 riding 2500 shares.. I'm accumulating shares of IceCure Literally has a cure rate for early breast cancer patients with a success rate at 97% with 5 year independent follow up DATA . Even more impressive is the late stage breast cancer data just came out with a year follow up with 92.5% success rate treating tumors twice the size as the ones treated in the early breast cancer patients. Cryoblast is seeing amazing results in Lung, Liver and Kidney Cancer. approved in 15 countries including Brazil, China and many EU countries. Insurance companies are on board and patients are using the technology in the USA but have to pay out of pocket until FDA approval. The minimally invasive medical space is growing companies like $PLSE went from 50 million market to a Billion in the last two years Pulse Biosciences and IceCure $ICCM have very cutting edge technology with better quicker results than surgery with procedures being done with local anesthetic in a in a doctors office being able to go home with in a few hours pretty remarkable. IceCure will see tremendous growth and one of the Richest families in Asia the Lee family Victor Lee an a early invester in Tencent owns 52% of IceCure shares.
$CADL.

PonkenPlonken

PonkenPlonken 5月前

Remember them buying up 450k shares a second after the readout was released on May23 all the way into high 16s.
sooner or later, the data will speak again and everyone will have to listen to whats being said.

Monksdream

Monksdream 5月前

falcon21

falcon21 6月前

added at 7.50 today

falcon21

falcon21 6月前

only 1.5 mil short

glenn1919

glenn1919 6月前

CADL................................a/h...................$$$$$$$$$$$$$$$$$$$$$$$$$$$

Monksdream

Monksdream 7月前

CADL under $10
Months

skidoo31

skidoo31 7月前

Short squeeze coming soon, mm have been borrowing my shares.

PonkenPlonken

PonkenPlonken 7月前

agree. mcap should be 1bln $+++.
institutions are waiting on the bid- then do the lifting on liquidity event.

LOTS of retail antihero-themed traders are short. Weak line of defense.

Roadtojourney

Roadtojourney 7月前

I cant believe this is still sitting at 5. The orphan designation for pancreatic itself is huge. Makes no sense. Imo

PonkenPlonken

PonkenPlonken 7月前

$CADL GROUNDBREAKING data... never before.
see latest presentation regarding pending data in nsclc and CRC
Check Paul Peter Tak vita... Its a home run

skidoo31

skidoo31 7月前

Good job, she’s got legs. Maybe it will cool off in the morning for another possible dip then it’s chart making time. Shorts are staying away from this one as the potential for blue sky breakout is very good.

Namaste Charting

Namaste Charting 7月前

$cadl. The next few hours should be engaging to say the least

Actualfactual

Actualfactual 7月前

Looking for a push towards previous double top of 11.30’s and then a breakout through to blue skies

Namaste Charting

Namaste Charting 7月前

Sure is! Added some $cadl $6.50's here

She's got that look!

skidoo31

skidoo31 7月前

https://ir.candeltx.com/news-releases/news-release-details/candel-therapeutics-receives-fda-orphan-drug-designation-can

skidoo31

skidoo31 7月前

Chart is building nicely ..

Awl416

Candel Therapeutics Receives FDA Orphan Drug Designation for CAN-2409 for the Treatment of Pancreatic Cancer

philaya

philaya 7月前

Short interest 0.89%...
Bears smarter than some.

philaya

philaya 7月前

Will buy...
Any time low good.

Roadtojourney

Roadtojourney 7月前

Thats it just goes up news and then sell on news?? There is no holding here??

skidoo31

skidoo31 7月前

Could be a blue sky breakout if all these fundamentals line up. Big potential here.

skidoo31

skidoo31 7月前

New here, do you have a link please? Thank you

stoxjock

stoxjock 7月前

I am Getting Ready for tomorrow's Blast-off Opening at $15+, as we could possibly see news at 8:30AM about a 'Private Placement' of maybe 5M Common shares 'Unit's @$15.00/share Plus each Warrant in the unit exercisable at $15/common share, upon dosing of the 1st Patient in the Phase 3 trial...with total 'Net proceeds' of around $140M giving Runway to EOY 2026!

stoxjock

stoxjock 7月前

This stock was 'walked down' in PPS Friday afternoon. I am fully loaded. This is going to move up north of $30+ next two months. It has catalyst "READOUTs' coming up next two months and then into 4rth Q. Do not sell out for peanuts profits if you want to make massive gains, just HODL it till EOY 2024.Also, very possible it could be taken out anytime...GLTA!

philaya

philaya 7月前

Fund easy...
With the positive meds.

Roadtojourney

Roadtojourney 7月前

All that volume and only up 3% lol??

philaya

philaya 7月前

fomo monday...
fun to watch.

philaya

philaya 7月前

friday selling...
nothing matter.

Monksdream

Monksdream 7月前

philaya

philaya 7月前

buy the dip...
got some.

Awl416

Awl416

Invest-in-America

Invest-in-America 7月前

CADL: See latest 'CHART', below!!!!

Awl416

This action is entertaining

axelvento

axelvento 8月前

ALERT- Cash Position: Cash and cash equivalents as of December 31, 2023 were $35.4 million, as compared to $70.1 million as of December 31, 2022. Based on current plans and assumptions, the Company expects that its existing cash and cash equivalents will be sufficient to fund its current operating plan into the fourth quarter of 2024

axelvento

axelvento 8月前

Phase 2 topline data for CAN-2409 in low-to-intermediate-risk, localized, non-metastatic prostate cancer expected in Q4 2024
Phase 3 topline data for CAN-2409 in localized intermediate/high-risk prostate cancer expected in Q4 2024

trader59

trader59 8月前

The dump here when the computers doing the trading are turned off is going to be brutal.

Candel Therapeutics

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約